Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Pediatr ; 241: 62-67.e1, 2022 02.
Artigo em Inglês | MEDLINE | ID: mdl-34626672

RESUMO

OBJECTIVES: To evaluate whether extremely preterm infants regulate iron status via hepcidin. STUDY DESIGN: In this retrospective analysis of infants from the Preterm Epo Neuroprotection (PENUT) Trial, urine hepcidin (Uhep) normalized to creatinine (Uhep/UCr) was evaluated among infants randomized to erythropoietin (Epo) or placebo. RESULTS: The correlation (r) between Uhep/UCr and serum markers of iron status (ferritin and zinc protoporphyrin-to-heme ratio [ZnPP/H]) and iron dose was assessed. A total of 243 urine samples from 76 infants born at 24-276/7 weeks gestation were analyzed. The median Uhep/UCr concentration was 0.3, 1.3, 0.4, and 0.1 ng/mg at baseline, 2 weeks, 4 weeks, and 12 weeks, respectively, in placebo-treated infants. The median Uhep/UCr value in Epo-treated infants were not significantly different, with the exception of the value at the 2-week time point (median Uhep/UCr, 0.1 ng/mg; P < .001). A significant association was seen between Uhep/UCr and ferritin at 2 weeks (r = 0.63; P < .001) and at 4 weeks (r = 0.41; P = .01) and between Uhep/UCr and ZnPP/H at 2 weeks (r = -0.49; P = .002). CONCLUSIONS: Uhep/UCr values correlate with serum iron markers. Uhep/UCr values vary over time and are affected by treatment with Epo, suggesting that extremely preterm neonates can regulate hepcidin and therefore their iron status. Uhep is suppressed in extremely preterm neonates, particularly those treated with Epo.


Assuntos
Creatinina/urina , Eritropoetina/administração & dosagem , Hepcidinas/urina , Lactente Extremamente Prematuro/metabolismo , Ferro/metabolismo , Biomarcadores/sangue , Ferritinas/sangue , Heme , Humanos , Lactente , Recém-Nascido , Protoporfirinas/sangue , Estudos Retrospectivos
2.
Br J Nutr ; 113(6): 901-8, 2015 Mar 28.
Artigo em Inglês | MEDLINE | ID: mdl-25745840

RESUMO

Prebiotics may increase intestinal Fe absorption in anaemic growing rats. The present study evaluated the effects of high-performance (HP) inulin and oligofructose on factors that regulate Fe absorption in anaemic rats during the growth phase. Male Wistar rats aged 21 d of age were fed AIN-93G ration without Fe for 2 weeks to induce Fe-deficiency anaemia. The rats were fed on day 35 a control diet, or a diet with 10 % HP inulin, or a diet with 10 % oligofructose, without Fe supplementation. The animals were euthanised after 2 weeks, and segments of the duodenum, caecum, colon and liver were removed. The expression levels of proteins in the intestinal segments were assessed using Western blotting. The levels of serum, urine and liver hepcidin and the concentrations of IL-10, IL-6 and TNF-α in the caecum, colon and liver were measured using the ELISA test. HP inulin increased the expression of the divalent metal transporter 1 protein in the caecum by 162 % (P= 0·04), and the expression of duodenal cytochrome b reductase in the colon by 136 % (P= 0·02). Oligofructose decreased the expression of the protein ferroportin in the duodenum (P= 0·02), the concentrations of IL-10 (P= 0·044), IL-6 (P= 0·036) and TNF-α (P= 0·004) in the caecum, as well as the level of urinary hepcidin (P< 0·001). These results indicate that prebiotics may interfere with the expression of various intestinal proteins and systemic factors involved in the regulation of intestinal Fe absorption in anaemic rats during the growth phase.


Assuntos
Anemia Ferropriva/dietoterapia , Proteínas de Transporte de Cátions/metabolismo , Grupo dos Citocromos b/metabolismo , Mucosa Intestinal/metabolismo , Prebióticos , Regulação para Cima , Anemia Ferropriva/imunologia , Anemia Ferropriva/metabolismo , Anemia Ferropriva/patologia , Animais , Proteínas de Transporte de Cátions/agonistas , Ceco/imunologia , Ceco/metabolismo , Ceco/patologia , Colo/enzimologia , Colo/imunologia , Colo/metabolismo , Grupo dos Citocromos b/química , Grupo dos Citocromos b/genética , Duodeno/imunologia , Duodeno/metabolismo , Duodeno/patologia , Hepcidinas/sangue , Hepcidinas/metabolismo , Hepcidinas/urina , Mediadores da Inflamação/metabolismo , Mucosa Intestinal/imunologia , Mucosa Intestinal/patologia , Inulina/efeitos adversos , Inulina/uso terapêutico , Fígado/imunologia , Fígado/metabolismo , Fígado/patologia , Masculino , Oligossacarídeos/efeitos adversos , Oligossacarídeos/uso terapêutico , Tamanho do Órgão , Prebióticos/efeitos adversos , Ratos Wistar , Aumento de Peso
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA